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DObjective(s): Congenital heart disease (CHD) and heterotaxy patients have increased postoperative and respi-
ratory complications. We recently showed CHD-heterotaxy patients can have respiratory ciliary dysfunction
(CD) similar to that associated with primary ciliary dyskinesia, including low nasal nitric oxide and abnormal
ciliary motion. In this study, we investigated whether CHD-heterotaxy patients with CD may have worse
postsurgical outcomes.
Methods:We examined postsurgical outcome in 13 heterotaxy-CHD patients with CD (25 surgeries), compared
with 14 heterotaxy-CHD patients without CD (27 surgeries). Outcome data were collected for each surgery,
including respiratory complications, tracheostomy, use of inhaled b-agonists or nitric oxide, length of hospital
stay, days on ventilator, and death.
Results: The CD versus the no-CD CHD cohorts had similar Risk Adjustment in Congenital Heart Surgery-1
risk categories, repair track, age at surgery, and follow-up evaluation times. Respiratory complications (76%
vs 37%; P ¼ .006), need for tracheostomy (16% vs 0%; P ¼ .047), and use of inhaled b-agonists (64% vs
11%; P ¼ .0001) all were increased significantly in heterotaxy-CHD patients with CD. No significant differ-
ences were detected in postoperative hospital stay, days on mechanical ventilation, or surgical mortality. A trend
toward increased mortality for the CD group beyond the postoperative period was observed (33% vs 0%;
P ¼ .055) in patients younger than age 10 years.
Conclusions: Our findings showed that heterotaxy-CHD patients with CD may have increased risks for respi-
ratory deficiencies. Overall, there was a trend toward increased mortality in CD patients with intermediate
follow-up evaluation. Because b-agonists are known to increase ciliary beat frequency, presurgical screening
for CD and perioperative treatment of CD patients with inhaled b-agonists may improve postoperative outcomes
and survival. (J Thorac Cardiovasc Surg 2014;147:1291-8)Supplemental material is available online.e Children’s National Heart Institute,a Department of Pediatric Pulmono-
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The Journal of Thoracic and CarHeterotaxy constitutes a wide spectrum of defects involving
abnormal left-right patterning of organ situs in the abdom-
inal and thoracic cavities. The aberrant left-right asymmetry
can range from milder forms involving a single organ sys-
tem to more complex disease involving indeterminate
patterning of multiple thoracoabdominal organs. Hetero-
taxy occurs in approximately 1 in 10,000 live births and is
associated with 3% of cases of congenital heart disease
(CHD).1-3 Despite significant advances in medical and
surgical management of CHD over the past few decades,
short- and long-term morbidity and mortality remain high
for CHD patients with heterotaxy.4-6
One study evaluating surgical outcomes after the Fontan
surgery showed a 2-fold higher postoperative mortality rate
for CHD patients with heterotaxy compared with CHD pa-
tients without heterotaxy.7 We previously showed in a retro-
spective study that 87 heterotaxy-CHD patients had more
postoperative complications, higher postoperative mortality
rates, and increased respiratory complications compared
with 634 CHD patients without laterality defects with
similar Risk Adjustment in Congenital Heart Surgery-1diovascular Surgery c Volume 147, Number 4 1291
Abbreviations and Acronyms
CD ¼ ciliary dysfunction
CHD ¼ congenital heart disease
ECMO ¼ extracorporeal membrane oxygenation
PCD ¼ primary ciliary dyskinesia
PLE ¼ protein-losing enteropathy
PVR ¼ pulmonary vascular resistance
RACHS-1 ¼ Risk Adjustment in Congenital Heart
Surgery-1
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D(RACHS-1) risk categories.8 Relevant to these findings are
observations from a Dnahc5 mutant mouse model of pri-
mary ciliary dyskinesia (PCD), which showed that PCD is
associated with a 40% incidence of CHD associated with
heterotaxy. This observation reflects the known requirement
for motile cilia function at the embryonic node for left-right
patterning, and the essential role of motile cilia function in
the respiratory epithelia for airway clearance.9 Together,
these findings suggest a common etiology involving ciliary
dysfunction in PCD and heterotaxy, and the respiratory
complications in these patients. Consistent with this, a
retrospective study of 337 PCD patients showed a 6% inci-
dence of heterotaxy, with 67% of the heterotaxy patients
showing CHD.10
To further investigate whether airway cilia dysfunction
may be linked with CHD associated with heterotaxy, we
conducted a study of CHD-heterotaxy patients to assess
the prevalence of airway ciliary dysfunction (CD). Patients
were evaluated with 2 tests normally used to diagnose PCD.
This included measurement of nasal nitric oxide, which is
typically low in PCD patients, and video microscopy of
nasal airway epithelia to examine possible abnormal airway
cilia motility. From these studies, we determined 42% of
patients with heterotaxy-CHD have CD similar to patients
with PCD, including low or borderline-low nasal nitric ox-
ide and abnormal airway ciliary motion.11 Furthermore,
sequencing analysis showed these patients were enriched
for mutations in 10 known PCD genes, and analysis of res-
piratory symptoms suggested CHD-heterotaxy patients
with CD older than 6 years of age have more respiratory
symptoms.
In this study, we prospectively examined this same
heterotaxy-CHD patient cohort, evaluating surgical out-
comes in the subset of patients who underwent cardiac sur-
gery. This included 52 surgical encounters in a total of 13
heterotaxy-CHD patients with CD (25 surgeries) and 14
heterotaxy-CHD patients without CD (27 surgeries). We
hypothesized that CHD-heterotaxy patients with CD may
have a higher morbidity/mortality rate and increased post-
operative complications compared with CHD-heterotaxy
patients without CD.1292 The Journal of Thoracic and Cardiovascular SurMETHODS
Case Selection
This study was approved and conducted in accordance with the Chil-
dren’s National Medical Center Institutional Review Board. Patients with
heterotaxy and CHD undergoing cardiac surgery at the Children’s National
Medical Center between 2005 and 2010 were enrolled prospectively in
the study based on the inclusion and exclusion criteria as previously
described.11 Nasal nitric oxide measurements and videomicroscopy of
airway epithelia were obtained during the preoperative evaluation or just
before discharge.11 Patient care team members were blinded to ciliary
function status throughout study. Briefly, heterotaxy in this study was
broadly defined as deviation from normal left-right asymmetry in any thor-
acoabdominal organ differing from situs solitus and situs inversus totalis.12
Therefore, our case cohort comprised patients with congenital heart defects
associated with laterality disorders, such as pulmonary, cardiovascular,
gastrointestinal, splenic, and/or hepatobiliary systems. CHD patients are
considered to have abnormal cardiovascular situs if they have dextrocardia/
mesocardia, interrupted inferior vena cava, atrial-isomerism/ambiguous/
inversus, atrioventricular discordance, superior/inferior ventricles, and
ventricular-arterial discordance. Phenotype can be solely cardiovascular in
nature without atrial isomerism. Isolated CHD comprising a double-outlet
right ventricle with no other situs defects was excluded.
Outcome Data Collection
Relevant medical history and preoperative data including age at surgical
intervention, preoperative weight, and history of neonatal respiratory
distress were obtained from the medical records. Detailed surgical data
and postoperative outcome data were recorded from progress notes,
respiratory care data sheets, surgical reports, and discharge summaries.
Postoperative length of stay; surgical procedures performed, particularly
single-ventricle versus biventricular surgical tracks; and their RACHS-1
risk categories were detailed for each surgical encounter.13 RACHS-1
risk categories have been shown to correlate well with in-hospital mortality
and length of postoperative hospital stay, which allows for relevant compar-
isons between different groups undergoing surgery for CHD.14
Postoperative mortality, defined by death within 30 postoperative days or
within thepostoperative hospital stay, andmortality beyond the postoperative
period were collected via the cardiothoracic surgical database or death
certificates in electronicmedical records. Extracorporealmembrane oxygen-
ation (ECMO) support and use of inotropic and pulmonary vasodilator
medications during the postoperative period were determined. Postoperative
respiratory outcome measures including length of mechanical ventilation,
placement of new tracheostomy, continued need for existing tracheostomy
for ventilation, use of inhaled b-agonists, duration of initial postoperative
chest tube, prolonged ventilatory course, and respiratory complications
were gathered for each surgical encounter. Patients with existing tracheos-
tomies preoperatively were evaluated thoroughly by the Department of
Pulmonology to determine whether the tracheostomy was needed for
ventilation. Respiratory complicationswere broadly defined to include failed
extubations, respiratory failure, culture or polymerase chain reaction–posi-
tive respiratory infection, stridor, and radiographic evidence of pleural
effusions, atelectasis, pneumothorax, and pulmonary edema.
A prolonged ventilatory coursewas defined as postoperativemechanical
ventilation for longer than 10 days based on analyzing the distribution of
postoperative mechanical ventilatory duration seen in our retrospective
study at this institution, which represented the upper 10% of cases.8 This
definition of a prolonged ventilatory course was used previously in a pedi-
atric cardiac surgical population.15 Preoperative pulmonary vascular resis-
tance (PVR) was obtained from cardiac catheterization reports for all
patients who underwent hemodynamic evaluation before surgical interven-
tion, with an increased PVR defined as 3 or more Woods unit 3 m2. Med-
ical records were reviewed extensively for a diagnosis or clinical suspicion
of protein-losing enteropathy (PLE) including perioperative albumin
levels. Length of follow-up evaluation was available for all patients andgery c April 2014
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Dwas defined as the time interval from the first surgical encounter for all sur-
viving patients. Similar data were collected for both patient cohorts.
Statistical Analysis
Continuous variables were shown as medians with interquartile ranges
and categoric variables were shown by frequencies and percentages. To
compare the CD and no-CD groups, the Mann-Whitney U test was used
for continuous variables and the Fisher exact test was used for categoric
variables. All tests were 2-tailed and P values less than .05 were considered
significant; no adjustments were made for multiple comparisons.
RESULTS
Postoperative outcome measures were analyzed in 13 pa-
tients with heterotaxy CHD with ciliary dysfunction (CD-
group), representing 25 surgical encounters (Table 1), and
14 patients with heterotaxy CHD with normal ciliary func-
tion (no-CD group), representing 27 surgical encounters
(Table 2). The structural heart lesion and laterality defects
observed in these patients are detailed in Table E1. Among
the 27 patients, 11 (41%) had cardiovascular situs defects
only and 16 (59%) had cardiovascular and other thoracoab-
dominal laterality defects. Specific visceral organ situs was
determined from available imaging (Table E1). Insufficient
visceral organ imaging to determine situs accurately was
found in 7 patients (26%). For available records, laterality
abnormalities compared with normal were present in heart
position (48%), stomach (47%), liver (61%), spleen
(67%), and bronchial airway/lung isomerism (100%) in
the few pulmonary imaging records.
Among all study participants, levocardia was present in
14 patients (52%), whereas abnormal cardiac position
was observed in 13 patients (48%), with dextrocardia ac-
counting for 11 cases (41%) and mesocardia accounting
for 2 cases (7%). Atrial situs solitus was seen in 14 patients
(52%), inversus in 7 patients (26%), and ambiguous in 6
patients (22%). Of the 6 patients with ambiguous atrial si-
tus, left isomerism was diagnosed in 2 patients (33%) and
right isomerism was diagnosed in 4 patients (67%). Ven-
tricular looping was D-looped in 19 patients (70%) and
L-looped in 8 patients (30%). Finally, the situs of the great
vessels was solitus in 3 patients (11%), dextroposed in 12
patients (45%), levoposed in 9 patients (33%), and indeter-
minate in 3 patients (11%).
Clinical and Surgical Characteristics
Clinical and surgical characteristics of the study groups
are shown in Tables 3 and 4. The patients’ ages ranged
from 2 days to 46 years at the time of surgery (median
age, 23.5 months and 6.8 months for CD and no-CD co-
horts, respectively). Seventeen patients (63%) were female
and 10 patients (37%) were male. Reflective of the overall
population seen at the Children’s National Medical Center,
40% were African American, 30% were Caucasian, 19%
were Asian, and 11%were Hispanic. The CD cohort under-
went 25 cardiac surgical procedures, whereas the no-CDThe Journal of Thoracic and Carcohort had 27 cardiac surgeries. The median number of car-
diac surgical procedures was 2 (range, 1-4) with median
RACHS-1 risk categories of 3.0 (range, 2-6) in the CD
and no-CD groups. Overall, 19 patients (70%) followed a
single-ventricle track and 8 patients (30%) underwent
biventricular repair. Preoperative weight was higher among
the CD group (median weight, 10.6 kg) compared with the
no-CD group (median weight, 7.7 kg), which is reflective of
the broader age range of CD patients undergoing cardiac
procedures.
Comparison of Postsurgical Outcomes
Comparison of age at surgery, preoperative weight,
race, and sex were not statistically different between the
heterotaxy-CHD patients with CD versus those with no-
CD (Tables 3 and 4). The RACHS-1 risk categories and
the surgical repair track were also not statistically different
(Tables 3 and 4). The median postoperative hospital stay for
the 25 surgical encounters of the CD cohort was 8 days
(mean, 19.3 days) (Table 3), which was not different from
the 27 surgical encounters of the no-CD cohort, which
had a median postoperative stay of 8 days (mean, 15 days)
(P ¼ .81). ECMO was required postsurgically for 1 patient
(4%) in the CD group versus 3 patients (11%) in the no-CD
group (Table 3), which was not statistically different. Preop-
erative hemodynamic assessment was obtained for 18
(72%) of the 25 CD surgical encounters and 19 (70%) of
the 27 no-CD surgical encounters. Increased pulmonary
vascular resistance (3Woods unit3m2) was found during
the preoperative hemodynamic assessment for 5 patients
(28%) in the CD group and for 3 patients (16%) in the
no-CD group, with no statistical difference seen (Table 3).
There were 2 patients (15%) with a diagnosis of PLE in
the CD group, both of whom died as described later, and
no patients with PLE in the no-CD group (Table 4). Use
of inotropic agents (milrinone, dopamine) and pulmonary
vasodilator agents (inhaled nitric oxide, sildenafil, bosen-
tan) was similar between the 2 groups.
Comparison of Morbidity and Mortality
We conducted a follow-up analysis of surviving patients
since their first surgical encounter. This encompassed 4.1
years for the CD cohort and 3.7 years for the no-CD cohort
(Table 4). We observed no deaths in the postoperative
period for the CD group and 1 death (patient 9029) in the
no-CD group. Patient 9029 died 22 days after a bidirectional
Glenn procedure and total anomalous pulmonary venous re-
turn repair from complications secondary to fungal sepsis
while on ECMO. There were 3 deaths (23%) in the CD
group beyond the postoperative period (>30 days) compared
with no deaths in the no-CD group (Table 4). Patient 9006
died of complications secondary to PLE 17 months after
Fontan completion. Patient 9008 had a diagnosis of PLE
and died 14 months after Fontan completion of group Adiovascular Surgery c Volume 147, Number 4 1293
TABLE 1. Heterotaxy patients with CHD and airway ciliary dysfunction
Patient or
study no. Age
Complete cardiovascular
anatomy* Procedure (RACHS-1) Other laterality defects nNO (nL/min)
9004 5 mo {S,D,D}Levocardia, unbalanced AVC,
DORV, D-malposed great vessels,
PS, LSVC to LA, RSVC to RA,
RV hypoplasia, right aortic arch
Bilateral bidirectional Glenn (2) Asplenia, liver/stomach
inversus
34 (low)
2.1 y Fontan (3)
9006y 8 mo {I,D,D}Dextrocardia, DORV, PA,
common atrium, PAPVR, atrial
inversus
Bidirectional Glenn (2) Bronchial inversus 61 (borderline)
2 y Fontan (3)
9008y 23 mo {S,D,D}Dextrocardia, truncus
arteriosus, VSD, ASD, LSVC
BT shunt (3) — 138 (borderline)
7.2 y Bilateral bidirectional Glenn,
pulmonary arterioplasty (2)
9.4 y Fontan (3)
9010 5 d {S,D,D}Levocardia, DORV, PS,
D-malposed great vessels, VSD
Pericardial baffle of VSD to aorta, RV
to pulmonary artery conduit (4)
— 59 (borderline)
4 mo Modified Konno with Gortex patch
ventriculoseptoplasty and resection
of subaortic stenosis (4)
20 mo Modified Konno with Gortexz patch
ventriculoseptoplasty, homograft
conduit change, resection of
subaortic stenosis, epicardial
pacemaker (2)
2.3 y Mitral valve replacement (3)
9011 11.7 y {A,D,D}Levocardia, unbalanced
AVC, HLV, PA, VSD, D-malposed
great vessels, bilateral SVC and
left-sided IVC to left-sided atrium,
pulmonary venous return to right-
sided atrium, right atrial isomerism
Excision of aneurysmal seroma,
aorto-LPA shunt revision (4)
Asplenia 85 (low)
9015 5 d {S,D,S}Levocardia, unbalanced
AVC, hypoplastic aortic arch,
coarctation of aorta, LSVC to LA
Norwood/Sano (6) Midline liver
9 mo Bidirectional Glenn (2) 2 (low)
9017 9 d {I,L,L}Dextrocardia, atrial/ventricular
inversus, DORV, L-malposed great
vessels, PA, VSD, right aortic arch,
LSVC and LIVC to left-sided
morphologic right atrium
BT shunt (3) Bronchial inversus,
abdominal situs inversus
3.4 y Bidirectional Glenn (2) (borderline)
5.9 y Fontan (4) 55
9020 40.1 y {S,L,L}Dextrocardia, DORV,
ventricular inversion, A-V
discordance, bilateral SVCs,
subpulmonary stenosis, VSD, left
aortic arch
BT shunt (3) — 90 (low)
9023y 8 d {I,L,L}Dextrocardia, DORV,
L-malposed great vessels, VSD,
right aortic arch, co-arctation of
aorta, supracardiac total anomalous
pulmonary venous drainage to
vertical vein, bridging vein to LSVC
Pulmonary artery banding,
coarctation of aorta repair, PDA
ligation (3)
Abdominal situs inversus
6.2 mo Bidirectional Glenn, TAPVR repair (4) 5 (low)
(Continued)
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TABLE 1. Continued
Patient or
study no. Age
Complete cardiovascular
anatomy* Procedure (RACHS-1) Other laterality defects nNO (nL/min)
9026 17.9 y {A,D,X}Dextrocardia, situs
ambiguous, HLHS, unbalanced
AVC, critical aortic valve stenosis,
coarctation of aorta, bilateral SVCs
with interrupted IVC and
hemiazygous continuation to
LSVC, right aortic arch, left atrial
isomerism
Fontan (3) Left bronchial isomerism,
polysplenia
162 (borderline)
9027 8.3 y {A,D,S}Levocardia, right aortic arch,
TOF with PA, MAPCAs, LSVC to
left atrium, left atrial isomerism
Aortic homograft takedown and
repair, residual VSD closure (3)
Left bronchial isomerism,
polysplenia
123 (borderline)
9031 12.7 y {I,L,L}Dextrocardia, atrial situs
inversus, L-malposed great vessels
Rastelli conduit replacement (3) Abdominal situs inversus 117 (borderline)
9043 14 d {A,L,D}Levocardia, DORV, HLV,
D-malposed great vessels, PA,
common atrium, ambiguous atrial
situs, TAPVR, right atrial
isomerism
BT shunt (3) Bronchial inversus, asplenia 9 (low)
6 mo Bidirectional Glenn (2)
All patients had normal cilia motion by videomicroscopy. ASD, Atrial septal defect; A-V, atrioventricular; AVC, atrioventricular canal defect; BT, Blalock Taussig;DORV, double-
outlet right ventricle; HLHS, hypoplastic left heart syndrome; HLV, hypoplastic left ventricle; IVC, inferior vena cava; LA, left atrium; LIVC, left inferior vena cava; LPA, left
pulmonary artery; LSVC, left superior vena cava; MAPCA, multiple aortopulmonary collateral; nNO, nasal nitric oxide; PA, pulmonary atresia; PAPVR, partial anomalous
pulmonary venous return; PDA, patent ductus arteriosus; PS, pulmonic stenosis; RA, right atrium; RACHS-1, Risk Adjustment in Congenital Heart Surgery-1; RSVC, right
superior vena cava; RV, right ventricle; SVC, superior vena cava; TAPVR, total anomalous pulmonary venous return; TOF, tetralogy of Fallot; VSD, ventricular septal defect.
*Van Praagh classification (1977). yMortality. zGore Medical, Flagstaff, Ariz.
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Dstreptococcus sepsis and cardiogenic shock in a failing
Fontan while on ECMO. Patient 9023 died 26 months after
a bidirectional Glenn and total anomalous pulmonary
venous return repair from culture-negative sepsis and com-
plications of dilated cardiomyopathy. There was no statis-
tical difference in postoperative mortality (30 days),
mortality beyond the postoperative period (>30 days), or
total mortality between the 2 study groups (Table 4). Over-
all, mortality for the CD group beyond the postoperative
period showed a trend toward significance (33% vs 0%,
P ¼ .055) when patients were stratified to exclude those
(n ¼ 4) older than 10 years of age.
Comparison of Respiratory Outcomes
Themedian length of postoperativemechanical ventilation
for the 25 CD surgical encounters was 1 day (mean, 11.7
days), with 5 surgical encounters (20%) experiencing pro-
longed ventilatory courses (Table 5). In comparison, the me-
dian length of postoperativemechanical ventilation for the 27
no-CD surgical encounterswas 1 day (mean, 4.2 days), with a
smaller proportion (7%; 2 surgical encounters) resulting in
prolonged ventilatory courses (Table 5). There was no statis-
tical difference in the median length of postoperative ventila-
tion (P ¼ .69) or prolonged ventilatory course (P ¼ .24)
between the CD versus no-CD groups. The median length
of initial postoperative chest tube requirement showed no sta-
tistical difference between groups, with the median lengthThe Journal of Thoracic and Carbeing 3 days (mean, 5.8 days) for the CD group and 3 days
(mean, 6.6 days) for the no-CD group (Table 5).
The frequency of respiratory complications, inhaled
b-agonist use, and tracheostomies was compared between
the 2 groups (Table 5). Respiratory complications occurred
after 19 (76%) cardiac surgeries in the CD cohort. In com-
parison, respiratory complications occurred after only 10
(37%) cardiac interventions in the no-CD group, which is
significantly less frequent (P<.006) than in the CD group.
The occurrence of respiratory complications for each surgical
encounter, the associated chest tube length, and inhaled
b-agonist use are shown in Tables E2 and E3. Subgroup
analysis of respiratory outcomes excluding those not known
to be caused by cilia dysfunction alone (pleural effusions,
stridor, and pulmonary edema) continued to show signifi-
cantly more respiratory complications in the CD cohort
(P<.022). Inhaled b-agonist use postoperatively was signifi-
cantly more frequent (P<.001) in the CD versus the no-CD
group. This was observed in 16 (64%) CD surgical cases
compared with 3 (11%) no-CD surgical cases. Finally, the
need for a new tracheostomy or the continued requirement
of an existing tracheostomy for ventilation was statistically
more frequent in the CD versus no-CD group (P<.047).
DISCUSSION
Prospective evaluation of 13 heterotaxy patients with
CHD and CD undergoing cardiac surgery showed increaseddiovascular Surgery c Volume 147, Number 4 1295
TABLE 2. Heterotaxy patients with CHD without airway ciliary dysfunction
Patient or
study no. Age Complete cardiovascular anatomy* Procedure (RACHS-1) Other laterality defects nNO (nL/min)
9005 4 d {S,D,S}Levocardia, VSD, ASD,
coarctation of aorta, interrupted IVC
with azygous continuation to RSVC
VSD patch closure, ASD suture
closure, coarctation repair (3)
Polysplenia, midline liver 12 (low)
9007 6 mo {A,D,L}Levocardia, situs ambiguous,
DORV, unbalanced AVC, superior/
inferior ventricles, L-malposed great
vessels, PS, bilateral SVCs, right aortic
arch, right atrial isomerism
Bilateral bidirectional Glenn (2) Asplenia, midline liver 86 (nl)
2.5 y Fontan (3)
9013 6.8 y {S,L,L}Dextrocardia, L-malposed great
vessels, PA, ASD, VSD, pulmonary
veins to RA, RSVC and RIVC to RA
RV/PA conduit replacement (3) — 115 (nl)
9014 2 d {S,D,X}Dextrocardia, superior/inferior
ventricles, D-malposed great vessels,
ASD, VSD, tricuspid stenosis, PA,
right aortic arch
BT shunt (3) —
4.5 mo Bidirectional Glenn (2)
2.1 y Fontan, atrial septectomy (4) 65 (nl)
9021 6 mo {S,L,L}Dextrocardia, L-TGA, VSD,
ASD, PS
Bidirectional Glenn, atrial septectomy,
tricuspid valvuloplasty (4)
— 23 (nl)
2.1 y Fontan (3)
9022 2 mo {S,D,D}Levocardia, DORV, VSD, ASD,
HLV, D-malposed great vessels, bilateral
SVCs, interrupted IVC with azygous
continuation to RSVC, LSVC to CS
PA band (3) — 56 (nl)
7 mo Bilateral bidirectional Glenn (4)
2.4 y Fontan (3)
9024 2.1 y {I,L,L}Dextrocardia, unbalanced AVC,
DORV inverted atria, PAPVR, L-malposed
great vessels, interrupted IVC with azygous
continuation to LSVC
Fontan (3) Abdominal situs ambiguous 56 (nl)
9025 5 d {I,D,D}Mesocardia, atrial situs inversus,
D-malposed great vessels, VSD, PA,
right aortic arch, left-sided SVC/IVC
BT shunt (3) Abdominal situs inversus,
bronchial inversus
10 (low)
4 mo Bidirectional Glenn (2)
20 mo Fontan (3)
9029y 5 mo {A,D,D}Levocardia, DORV, D-malposed
great vessels, HRV, PS, VSD, TAPVR,
right aortic arch, bilateral SVCs,
interrupted IVC with azygous
continuation, right atrial isomerism
Bidirectional Glenn, TAPVR repair (3) Bronchial right isomerism,
midline liver, asplenia
33 (low)
9039 6 d {S,D,D}Levocardia, D-TGA Arterial switch (3) — 19 (low)
9044 26 d {S,D,D}Levocardia, single ventricle,
DILV, MS, AS, D-malposed great
vessels, coarctation of aorta
Norwood, BT shunt (6) — 22 (low)
9 mo Bidirectional Glenn, patch aortoplasty
of neoaorta (4)
23 mo Fontan (3)
9045 1 mo {S,D,D}Levocardia, DORV, PA, ASD,
VSD, LSVC to CS
VSD patch closure, RV/PA
conduit (3)
— 33 (low)
9046 9.3 y {I,D,X}Mesocardia, atrial situs inversus,
DORV, PA, VSD, right aortic arch,
bilateral SVCs
Bidirectional Glenn (2) Abdominal situs inversus,
bronchial inversus
238 (nl)
10.1 y Fontan (3)
(Continued)
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TABLE 2. Continued
Patient or
study no. Age Complete cardiovascular anatomy* Procedure (RACHS-1) Other laterality defects nNO (nL/min)
9049 16 d {S,D,L}Levocardia, DORV, superior/
inferior ventricles, criss-cross AV
valves, VSD, TS
Pulmonary artery band (3) — 14 (low)
6 mo Bidirectional Glenn (2)
20 mo Fontan (3)
All patients had abnormal cilia motion by videomicroscopy. AS, Aortic stenosis; ASD, Atrial septal defect; AV, atrioventricular; AVC, atrioventricular canal defect; BT, Blalock
Taussig; CS, coronary sinus; DILV, double-inlet left ventricle; DORV, double-outlet right ventricle; HLHS, hypoplastic left heart syndrome; HLV, hypoplastic left ventricle;
HRV, hypoplastic right ventricle; IVC, inferior vena cava; LA, left atrium; LIVC, left inferior vena cava; LSVC, left superior vena cava; MAPCA, multiple aortopulmonary
collateral; MS, mitral valve stenosis; nNO, nasal nitric oxide; PA, pulmonary atresia; PAPVR, partial anomalous pulmonary venous return; PDA, patent ductus arteriosus;
PS, pulmonic stenosis; RA, right atrium; RACHS-1, Risk Adjustment in Congenital Heart Surgery-1; RIVC, right inferior vena cava; RSVC, right superior vena cava; RV, right
ventricle; SVC, superior vena cava; TAPVR, total anomalous pulmonary venous return; TGA, transposition of the great vessels; TOF, tetralogy of Fallot; TS, tricuspid valve
stenosis; VSD, ventricular septal defect. *Van Praagh classification (1977). yMortality.
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heterotaxy-CHD patients with no CD. CHD patients with
CD showed increased postoperative respiratory complica-
tions, increased use of inhaled b-agonists, and a greater
need for a new tracheostomy or continued requirement of
an existing tracheostomy for ventilation. We observed no
difference in early postsurgical mortality between the 2
groups. However, intermediate follow-up evaluation in the
postsurgical period showed a trend toward increased
mortality in the CD patients.
Our study showed significantly more respiratory compli-
cations using our broad definition during the postoperative
hospitalization period for the CD cohort. CD may play an
important role in the development of certain respiratory
complications seen in our study, including atelectasis,
pneumothorax, failed extubations, respiratory failure, and
respiratory infection. However, CD alone cannot explain
pleural effusions, the most commonly occurring respiratory
complication in our study, and needs to be studied further.
Repeat analysis excluding respiratory complications not
known to be caused directly by ciliary dysfunction continued
to show significantly more complications in the CD group.
The finding of increased use of inhaled b-agonists during
the postoperative period in patientswith CDwas unexpected
because the use of inhaled b-agonists generally is avoided in
cardiac patients because of the proarrhythmic properties of
such medications. Administration usually is reserved only
for patients who have failed other medicinal andmechanical
interventions for respiratory symptoms such as atelectasisTABLE 3. Characteristics by surgical encounter
CD (n ¼
Age at surgery (mo), median (IQR) 23.5 (5.6-
Preoperative weight (kg), median (IQR) 10.6 (5.0-
RACHS-1 risk category, median (IQR) 3 (2-3
Postoperative stay (d), median (IQR) 8 (6-1
Increased PVR (3 Woods unit 3 m2), n (%)* 5 (28)
ECMO, n (%) 1 (4)
CD, Ciliary dysfunction; ECMO, extracorporeal membrane oxygenation; IQR, interquartile
ital Heart Surgery-1. *Seven and 8 patients had missing PVR values in the CD and no-CD
The Journal of Thoracic and Carandmucous impaction. These findings are particularly inter-
esting in light of increasing evidence that inhaled b-agonists
increase ciliary beat frequency.16-19 Such findings would
suggest the prophylactic treatment of heterotaxy-CHD
patients with CD with inhaled b-agonists may have the po-
tential to improve postoperative outcomes and survival.
Larger studies are needed to further investigate the obser-
vational finding of increased inhaled b-agonist use in CD
patients and how it alters the postsurgical course because
this was not examined in our prospective study.
Our study did not detect a significant increase in pulmo-
nary vascular resistance, or in the use of inhaled nitric oxide
or ECMO support. We also did not observe any difference
in length of postoperative hospital stay, length of posto-
perative mechanical ventilation, or prolonged ventilatory
courses. This contrasts with the positive findings from our
previous retrospective study that showed an increased
mean length of postoperative hospital stay, mechanical
ventilation, ECMO support, and prolonged ventilatory
course in heterotaxy patients (n ¼ 87) when compared
with nonheterotaxy patients (n¼ 634).8 When enrolling pa-
tients for this prospective study, patients were excluded if
they had compounding factors that may have altered their
ciliary function assessment by nasal nitric oxide and video-
microscopy. Therefore, our patient cohort may have been
healthier than the patients in our retrospective study. Given
the very small sample size of the present study, further
analysis of a larger cohort of patients is needed to further
evaluate the effect of CD on these outcome parameters.25) No-CD (n ¼ 27) P value
86.5) 6.8 (1.9-25.2) .15
23.0) 7.7 (4.2-10.6) .14
) 3 (3-3) .82
5) 8.0 (6-15) .81
3 (16) .45
3 (11) .61
range; PVR, pulmonary vascular resistance; RACHS-1, Risk Adjustment in Congen-
groups, respectively.
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TABLE 4. Patient characteristics
CD
(n ¼ 13)
No-CD
(n ¼ 14)
P
value
Repair track, n (%) >.99
Biventricular 4 (31) 4 (29)
Single ventricular 9 (69) 10 (71)
Death  30 d, n (%) 0 (0) 1 (7) >.99
Death>30 d, n (%) 3 (23) 0 (0) .098
Total mortality, n (%) 3 (23) 1 (7) .33
PLE, n (%) 2 (15) 0 (0) .22
Neonatal respiratory distress, n (%) 0 (0) 0 (0) >.99
Follow-up period since first
surgery for surviving
patients (y), median (IQR)
4.1 (3.5-5.4) 3.7 (3.2-3.7) .27
CD, Ciliary dysfunction; IQR, interquartile range; PLE, protein-losing enteropathy.
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difficulty in evaluating all of the possible confounding vari-
ables in the postoperative critical care period including
practice variability among providers. There was also diffi-
culty in the evaluation of noncardiac laterality defects
because there often was insufficient imaging data available
to perform a complete assessment of visceral organ lateral-
ity. Also not documented in the medical records were the
reason(s) why each patient was given an inhaled b-agonist
and whether clinical improvement was observed after treat-
ment. In addition, our study was not large enough to
perform a subanalysis of the CD cohort to determine if
patients given b-agonists had better outcomes and fewer
respiratory complications.CONCLUSIONS
Our study showed heterotaxy-CHD patients with CD
have increased risks for respiratory complications, greater
need for a tracheostomy, and increased use of inhaled
b-agonists. A trend toward increased mortality for the CD
group beyond the postoperative period was seen in patients
younger than age 10 years. Airway ciliary dysfunction
indeed could be a marker of other systemic diseases, giving
heterotaxy patients an inborn weakness in defendingTABLE 5. Respiratory outcome measures by surgical encounter
CD
(n ¼ 25)
No-CD
(n ¼ 27)
P
value
Mechanical ventilation (d), median (IQR) 1 (1.0-3) 1 (1-3) .69
Chest tube length (d), median (IQR) 3 (2-6) 3 (2-7) .98
Prolonged ventilatory course ( 10 d),
n (%)
5 (20) 2 (7) .24
Respiratory complications, n (%) 19 (76) 10 (37) .006
Total tracheostomies, n (%)* 4 (16) 0 (0) .047
New tracheostomies, n (%) 2 (9) 0 (0) .21
Inhaled b-agonists use, n (%) 16 (64) 3 (11) .001
CD, Ciliary dysfunction; IQR, interquartile range. *Includes new tracheostomies as
well as existing tracheostomies required for ventilation.
1298 The Journal of Thoracic and Cardiovascular Surpostoperative stresses. Larger studies are needed to further
investigate respiratory complications and the emergence of
respiratory symptoms and disease during long-term follow-
up evaluation in heterotaxy-CHD patients with CD. Such
studies may suggest the need for changing the standard of
care for these high-risk heterotaxy-CHD patients to include
preoperative screening for CD and instituting aggressive
perioperative pulmonary therapy for those with CD to
help improve postsurgical outcomes.
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TABLE E1. Cardiovascular anatomy and organ situs
Cardiovascular anatomy CD, n (%) No-CD, n (%) Organ situs CD, n (%) No-CD, n (%)
Cardiac position Stomach
Dextrocardia 7 (54) 4 (29) Normal 5 (38) 4 (29)
Mesocardia — 2 (14) Opposite 4 (31) 3 (21)
Levocardia 6 (46) 8 (57) Midline — 1 (7)
No record 4 (31) 6 (43)
Venous anomalies
Interrupted inferior vena cava 1 (8) 4 (29) Liver
Bilateral superior vena cava 7 (54) 5 (36) Normal 4 (31) 3 (21)
Anomalous pulmonary venous return 3 (23) 3 (21) Opposite 4 (31) 2 (14)
Midline 1 (8) 4 (29)
Atria and ventricles No record 4 (31) 5 (36)
Atrioventricular discordance 4 (31) 5 (36)
Atrioventricular septal defect 4 (31) 2 (14) Spleen
Atrial septal defect 1 (8) 6 (43) Normal 3 (23) 3 (21)
Ventricular septal defect 8 (62) 10 (71) Right 3 (23) 2 (14)
Atrioventricular valve atresia/stenosis — 2 (14) Asplenia 2 (15) 2 (14)
Common atrium 2 (15) — Polysplenia 2 (15) 1 (7)
No record 3 (23) 6 (43)
Ventricular outflow and great vessels Lungs
Ventriculoarterial discordance 10 (77) 11 (79) Normal — —
Double-outlet right ventricle 7 (54) 7 (50) Inverted 3 (23) 2 (14)
Pulmonary stenosis/atresia 8 (62) 8 (57) Left isomerism 2 (15) —
Truncus arteriosus 1 (8) — Right isomerism — 1 (7)
Aortic stenosis/atresia 1 (8) 1 (7) No record 8 (62) 11 (79)
Coarctation 3 (23) 2 (14)
Right arch 5 (38) 5 (36)
Double inlet left ventricle — 1 (7)
Van Praagh classification*
{S,D,S} 1 (8) 1 (7)
{S,D,D} 3 (23) 4 (29)
{S,L,L} 1 (8) 2 (14)
{S,D,X} — 1 (7)
{S,D,L} — 1 (7)
{I,L,L} 3 (23) 1 (7)
{I,D,D} 1 (8) 1 (7)
{I,D,X} — 1 (7)
{A,D,D} 1 (8) 1 (7)
{A,D,S} 1 (8) —
{A,D,L} — 1 (7)
{A,D,X} 1 (8) —
{A,L,D} 1 (8) —
CD, Ciliary dysfunction. *Van Praagh classification (1977).
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TABLE E2. Respiratory complications in heterotaxy patients with ciliary dysfunction
Surgical
encounter
Chest tube
length (d)
b-agonist
use
Pleural
effusions Atelectasis Pneumothorax
Failed
extubation
Respiratory
failure
Respiratory
infection Stridor
Pulmonary
edema Tracheostomy
9004 5 mo 2 Y x
2.1 y 8 N
9006 8 mo 11 Y
2 y 2 Y x
9008 23 mo 5 N x x
7.2 y 2 N x x
9.4 y 2 Y x x x
9010 5 d 2 Y
4 mo 2 Y
20 mo 2 Y
2.3 y 3 Y
9011 11.7 y 6 N x x
9015 5 d 47 Y x x x x
9 mo 4 Y x
9017 9 d 1 N x
3.4 y 3 N
5.9 y 8 N x
9020 40.1 y 11 Y x x
9023 8 d 5 Y x x x x
6.2 mo 4 Y x x
9026 17.9 y 6 N x
9027 8.3 y 2 Y x x
9031 12.7 y 2 N x
9043 14 d 2 Y x x
6 mo 2 Y x
TABLE E3. Respiratory complications in heterotaxy patients without ciliary dysfunction
Surgical
encounter
Chest tube
length (d)
b-agonist
use
Pleural
effusions Atelectasis Pneumothorax
Failed
extubation
Respiratory
failure
Respiratory
infection Stridor
Pulmonary
edema Tracheostomy
9005 4 d 3 N x
9007 6 mo 2 N
2.5 y 29 N x x
9013 6.8 y 2 N
9014 2 d 4 N x
4.5 mo 2 N
2.1 y 7 N x
9021 6 mo 3 N x
2.1 y 7 N
9022 2 mo 7 N x
7 mo 2 N x
2.4 y 1 N x x
9024 2.1 y 26 N x
9025 5 d 2 N
4 mo 1 N
20 mo 6 N
9029 5 mo 22 Y x
9039 6 d 1 Y x
9044 26 d 19 N
9 mo 3 N
23 mo 4 N
9045 1 mo 2 Y
9046 9.3 y 2 N
10.1 y 14 N
9049 16 d 1 N
6 mo 2 N
20 mo 5 N
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